Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst. — Memphis, Tennessee

Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst. is a clinical research site located in Memphis, Tennessee, United States 38104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst. has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung.

Sponsors: OSI Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst.?

Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst. conducted?

Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst. has 1 clinical trials on record. Their work covers Carcinoma, Non-Small-Cell Lung.

Is Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst. accredited by Crixeo Health?

Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.